Hiroshi Sasaki

Summary

Affiliation: Jikei University School of Medicine
Country: Japan

Publications

  1. doi request reprint Lateral view dissection of the prostato-urethral junction to reduce positive apical margin in laparoscopic radical prostatectomy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Minato ku, Tokyo, Japan
    Int J Urol 16:664-9. 2009
  2. doi request reprint Upfront transection and subsequent ligation of the dorsal vein complex during laparoscopic radical prostatectomy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 17:960-1. 2010
  3. ncbi request reprint Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients
    Takahiro Kimura
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 21:473-8. 2014
  4. pmc Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)
    Manabu Aoki
    Department of Radiology, The Jikei University School of Medicine, 3 25 8 Nishi shimbashi, Minato ku, Tokyo 105 8461, Japan
    J Radiat Res 55:527-32. 2014
  5. ncbi request reprint Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 21:572-7. 2014
  6. pmc Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer
    Hidetoshi Kuruma
    Department of Urology, Jikei University School of Medicine, 3 25 8 Nishi shimbashi, Minato ku, Tokyo, Japan
    Am J Pathol 174:2044-50. 2009
  7. doi request reprint The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years
    Norihiro Hayashi
    Department of Urology, Division of Clinical Research and Development, Jikei University School of Medicine, Minato ku, Tokyo, Japan
    BJU Int 109:515-9. 2012
  8. pmc Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial
    Kenta Miki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    BMC Cancer 10:572. 2010
  9. ncbi request reprint Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma
    Satoshi Takakura
    Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
    Int Surg 92:202-8. 2007
  10. ncbi request reprint Primary intrapelvic lymphaticovenular anastomosis following lymph node dissection
    Meisei Takeishi
    Department of Plastic and Reconstructive Surgery, Jikei University School of Medicine, Minatoku Tokyo, Japan
    Ann Plast Surg 57:300-4. 2006

Collaborators

Detail Information

Publications16

  1. doi request reprint Lateral view dissection of the prostato-urethral junction to reduce positive apical margin in laparoscopic radical prostatectomy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Minato ku, Tokyo, Japan
    Int J Urol 16:664-9. 2009
    ..To assess the impact of lateral view apical dissection in laparoscopic radical prostatectomy (LRP) on the reduction of positive surgical margin rates and recovery of postoperative continence...
  2. doi request reprint Upfront transection and subsequent ligation of the dorsal vein complex during laparoscopic radical prostatectomy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 17:960-1. 2010
    ..A stitch in a Z-shaped fashion is then applied to the entire transected stump of the DVC. This procedure is simple and easily performed, even by those with limited experience. Here we provide an overview of our current technique...
  3. ncbi request reprint Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients
    Takahiro Kimura
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 21:473-8. 2014
    ..To analyze mid-term oncological outcomes of low-dose rate brachytherapy in Japanese patients...
  4. pmc Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)
    Manabu Aoki
    Department of Radiology, The Jikei University School of Medicine, 3 25 8 Nishi shimbashi, Minato ku, Tokyo 105 8461, Japan
    J Radiat Res 55:527-32. 2014
    ..The pre-HDR PSA ≤ 0.1 subgroup had significantly improved bRFS. Further studies are needed to confirm the relevance of pre-HDR PSA in trimodality therapy. ..
  5. ncbi request reprint Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    Int J Urol 21:572-7. 2014
    ..To characterize local recurrence of prostate cancer and to assess the effect of salvage partial brachytherapy after primary 125-iodine low-dose rate brachytherapy with or without external beam radiotherapy in Japanese men...
  6. pmc Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer
    Hidetoshi Kuruma
    Department of Urology, Jikei University School of Medicine, 3 25 8 Nishi shimbashi, Minato ku, Tokyo, Japan
    Am J Pathol 174:2044-50. 2009
    ..As SND1 mRNA was overexpressed in cancer cells, the growth of these cells was suppressed following SND1 knockdown in vitro, thus representing a promising prostate cancer biomarker and therapeutic target...
  7. doi request reprint The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years
    Norihiro Hayashi
    Department of Urology, Division of Clinical Research and Development, Jikei University School of Medicine, Minato ku, Tokyo, Japan
    BJU Int 109:515-9. 2012
    ..To investigate the relationship between serum triglyceride (TG) levels and the incidence and characteristics of prostate cancer detected on biopsy...
  8. pmc Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial
    Kenta Miki
    Department of Urology, Jikei University School of Medicine, Tokyo, Japan
    BMC Cancer 10:572. 2010
    ..Data on the efficacy of combining androgen-deprivation therapy (ADT) with 125I-TPPB in this group remain limited and consequently the guidelines of the American Brachytherapy Society (ABS) provide no firm recommendations...
  9. ncbi request reprint Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma
    Satoshi Takakura
    Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
    Int Surg 92:202-8. 2007
    ..The estimated 3- and 5-year survival rates were 69% and 69%, respectively. Our current data and previous reports suggest that P-CPT is a candidate first-line chemotherapy regimen for OCCA...
  10. ncbi request reprint Primary intrapelvic lymphaticovenular anastomosis following lymph node dissection
    Meisei Takeishi
    Department of Plastic and Reconstructive Surgery, Jikei University School of Medicine, Minatoku Tokyo, Japan
    Ann Plast Surg 57:300-4. 2006
    ..This surgical modality is effective in preventing lymphedema in lower extremities after intrapelvic para-aortic lymph node dissection...
  11. ncbi request reprint Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer
    Seiji Isonishi
    Department of Obstetrics and Gynecology, Jikei University School of Medicine, 4 11 1 Izumi honnchou, Komae, Tokyo 201 8601, Japan
    Gynecol Oncol 93:647-52. 2004
    ....
  12. doi request reprint Evaluation of rectal bleeding factors associated with prostate brachytherapy
    Manabu Aoki
    Department of Radiology, Jikei University School of Medicine, Tokyo, Japan
    Jpn J Radiol 27:444-9. 2009
    ..To analyze rectal bleeding prognostic factors associated with prostate brachytherapy (PB) or in combination with external-beam radiation therapy (EBRT) and to examine dosimetric indications associated with rectal bleeding...
  13. ncbi request reprint [Prostatic cancer in a young adult: a report of 2 cases]
    Hiroshi Sasaki
    Department of Urology, Jikei University School of Medicine
    Hinyokika Kiyo 50:57-9. 2004
    ..Transrectal needle biopsy revealed poorly differentiated adenocarcinoma. Hormone therapy and radiation therapy were performed. Twenty-one cases reported in Japan in addition to the present cases are reviewed...
  14. ncbi request reprint A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype
    Akihiro Ishiguro
    Department of Pharmacy, Faculty of Medicine, University of Tokyo Hospital, 7 3 1 Hongoh, Bunkyo, Tokyo, Postal code 113 8655, Japan
    Clin Chim Acta 347:217-21. 2004
    ..5-kb XbaI haplotype in a Japanese woman. We developed a long PCR assay to distinguish CYP2D6*5 and the novel mutant allele, and we evaluated the PCR method on 162 different genomic DNA samples...
  15. ncbi request reprint Screening program of prostate cancer at Tokai University Hospital: characterization of prostate-specific antigen measurement
    Masatoshi Tokunaga
    Department of Urology, Tokai University School of Medicine, Kanagawa, Japan
    Tokai J Exp Clin Med 30:103-10. 2005
    ..We recommend that all men aged 50 years or older undergo testing for PSA to detect PC at an early stage...
  16. ncbi request reprint Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
    Kimio Ushijima
    Japan Gynecologic Cancer Study Group, Tokyo, Japan
    J Clin Oncol 25:2798-803. 2007
    ..To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women...